# Olema Pharmaceuticals, Inc. (OLMA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/OLMA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -53.09M | $ -45.99M | $ 956.0K | $ 480.48M |
| 2025 | $ 0 | $ -166.34M | $ -150.22M | $ 1.19M | $ 478.56M |
| 2024 | $ 0 | $ -136.09M | $ -109.85M | $ 1.43M | $ 408.96M |
| 2023 | $ 0 | $ -104.51M | $ -90.53M | $ 2.42M | $ 253.90M |
| 2022 | $ 0 | $ -117.06M | $ -92.08M | $ 2.57M | $ 197.55M |
| 2021 | $ 0 | $ -84.51M | $ -62.12M | $ 3.29M | $ 284.57M |
| 2020 | $ 0 | $ -28.18M | $ -25.38M | $ 0 | $ 338.14M |
| 2019 | $ 0 | $ -1.31M | $ -1.09M | $ 0 | $ -10.59M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.10 |
| Current Ratio | 10.88 |

## Other views

- [Metrics](https://sponda.capital/en/OLMA.md)
- [Charts](https://sponda.capital/en/OLMA/charts.md)
- [Compare](https://sponda.capital/en/OLMA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.